Find a Doctor

Return to Physician Search

Physician Profile


Miguel Islas-Ohlmayer, M.D

Board certified in hematology and internal medicine, Dr. Islas-Ohlmayer has a passion for helping patients with difficult situations. His particular interests include hematologic malignancies and stem cell transplants. He is fluent in Spanish.
Learn More.


Blood & Marrow Transplants
Medical Oncology




or call


Medical Oncology


Hematologic malignancies
Stem cell transplants




Universidad de Monterrey School of Medicine


Valley Baptist Medical Center/University of Texas Health Center


University of Texas Southwestern Medical Center
University of Texas Health Science Center/Texas Transplant Institute


Certified, American Board of Internal Medicine
Certified, Hematology Board of Internal Medicine
Licensed, Ohio Medical Board


American Society of Clinical Oncology
American Society of Hematology
American Society of Blood and Marrow Transplantation

Shaughnessy P, Islas-Ohlmayer M, Murphy J, HoughamM, Macpherson J, Winkler K, Silva M, Steinberg M, Matous J, Selvey S,  Maria M, McSweeeney PA. Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor compared to G-CSF and Cyclophosphamide. Biology of Blood and Marrow Transplantation, Aug 30 2010, vol 16, S212

Petra D. Cravens, Michael W. Melkus,  Angela Padgett-Thomas, Miguel Islas-Ohlmayer, Maria del P. Martin, J. Victor Garcia. Development and Activation of Human Dentritic Cells In Vivo in a Xenograft Model of Human Hematopoiesis. Stem Cells (2005) 23:264 -278

Brian W. Binck, May F. Tsen, Miguel Islas, D. Jean White, Roger A. Schultz, Monte S. Wills, J. Victor Garcia, Jureta W. Horton, James A. Thomas. Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock. American Journal of Physiology – Heart and Circulatory Physiology (2005) 288: H577 – H583

Islas-Ohlmayer M, Padget-Thomas A, Melkus M,  Cravens P, Martin M, Garcia J.V. Experimental Infection of NOD/SCID Mice Reconstituted with Human CD34+  Cells with Epstein-Barr Virus. Journal of Virology (2004) 78: 13891-13900.

Palucka AK , Gatlin J, Blanck JP, Melkus M, Clayton S, Ueno H, Kraus ET,   Cravens P, Bonnet L, Padgett-Thomas A, Marches F, Islas-Ohlmayer M, Garcia JV, Banchereau J. Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood (2003) 102: 3302 - 3310

Gatlin J, Islas-Ohlmayer M, Garcia J.V. Detection and titration of lentivirus vector preparations. Methods in Molecular Biology (2003) 229:57 - 68

As a member of our OHC physician team, Dr. Islas-Ohlmayer has full access to the OHC Clinical Trial research program.

We encourage our patients to discuss all of their healthcare options — including Clinical Trial research programs — with their doctor.

The following are recent reviews provided by actual OHC patients:

“He is very knowledgeable and takes the time to discuss your situation. I am not treated as a number. Nurses are friendly and ease anxiety.”

“Specialized care for my leukemia. Always had an answer for any new issues that arose during my treatment.” 

“Dr. Islas is concerned about my health and helps me understand my issues and options.” 

"We just love Dr. Islas. He is kind, exacting, and he really cares." 

“It's always nice to see my doctor after a successful bone marrow transplant.” 

“Dr Islas is a wonderful and caring Dr. He listens to you and takes the time to answer any questions.”